News Focus
News Focus
Followers 78
Posts 4418
Boards Moderated 0
Alias Born 01/17/2003

Re: AVII77 post# 115008

Tuesday, 04/25/2017 11:26:21 AM

Tuesday, April 25, 2017 11:26:21 AM

Post# of 828387
They said this in Jan 2016. I doubt their lawyer would have let them say this if the enrollment hold was for an IA that put their ph 3 trial results in question at the time. They would have put themselves on dangerous ground when already under legal attack by multiple lawsuits:

BETHESDA, MD, January 8, 2016 – Northwest Biotherapeutics (NASDAQ: NWBO) (“NW Bio”), a U.S. biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today issued the following statement addressing the sharp decline in the Company’s stock:

Global markets are experiencing serious concerns, many biotech companies’ stocks have fallen dramatically, and NW Bio believes that its stock is being heavily impacted by these serious adverse market conditions. NW Bio is not aware of any fundamental Company-related reason for the substantial decline in the price of the Company’s stock at this time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News